Inventor · disambiguated record
Zhengnian Li
Also filed as: LI ZHENGNIAN
2 granted patents·8 pending applications·4 citations·filing 2019–2023
42Inventor score
Top patents by PatentIndex Score
10 records- 0184US11807606B2Sulfonamide derivatives for protein degradationDANA FARBER CANCER INST INC·Filed 2019·Granted Nov 7, 2023·4 cites·24 claims
- 0261US2023304024A1Modulation of Gene Expression Via Transcription Factor-Chemically Induced Proximity (TF-CIP)UNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 0360US2023339922A1Covalent egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 0460US2025221998A1Discovery of covalent egfr inhibitor through cysteine 775DANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 0558US2023295137A1Covalent egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 0657US2024352021A1Covalent egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0756US2024166665A1Covalent egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0849US12318452B2Degraders of WEE1 kinaseDANA FARBER CANCER INST INC·Filed 2019·Granted Jun 3, 2025·0 cites·19 claims
- 0949US2023271932A1Small molecule covalent activators of ucp1DANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1048US2021230101A1Compounds for treating dengue virus infections and other infectionsDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhengnian Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →